It’s no secret that mental health is a pressing issue, with one in four people experiencing a mental health disorder each year. What’s more, these disorders cost the global economy $2.5 trillion annually. Despite this, there has been a lack of investment in psychedelic medicine research and development.

This could be about to change. A recent wave of investment in psychedelic medicine start-ups is taking place, with over $200 million invested in the space this year—and this is only set to increase.

If you want to fund psychedelic medicine start-ups to support psychedelic research, get in touch with The Conscious Fund.

Psychedelic substances are currently illegal in the United States, but that may change soon. Psilocybin, MDMA, and LSD are not currently considered drugs of abuse, but they are classified as Schedule I substances with “no currently accepted medical use and a high potential for abuse.” However, researchers have been studying the potential therapeutic benefits of psychedelics for years. A growing body of evidence suggests that these drugs could be used to treat conditions like anxiety, depression, addiction, and post-traumatic stress disorder.

In this blog post, you’ll learn how psychedelic medicine start-ups can help save mental health.

1. Reducing the Stigma Associated with Psychedelic Drugs

Public perceptions of psychedelic drugs are still largely negative, thanks in part to the War on Drugs. Psychedelic medicine start-ups can help reduce the stigma associated with these drugs by increasing public awareness of their therapeutic potential. By raising awareness and educating the public about the benefits of psychedelics, psychedelic start-ups can help change people’s perceptions of these substances and reduce their stigma.

2. Promoting Research into the Therapeutic Benefits of Psychedelics

Psychedelic medicine start-ups can help promote research into the therapeutic benefits of psychedelics and increase our understanding of these substances. By funding psychedelic research and promoting collaboration between researchers, these start-ups can help advance our knowledge of the therapeutic potential of psychedelics.

3. Providing Support for People Who Are Struggling

Addiction and mental health disorders can be extremely difficult to deal with, and people struggling with these conditions can often feel alone and isolated. Support networks like 12-step programs or mental health support groups can be incredibly helpful for people dealing with these issues. 12-step programs are free to attend, and many mental health support groups also offer free services.

4. Offering Online Resources and Support

People who are in a battle with mental health disorders can often find it difficult to access information about the available resources. Online resources can be a great way to provide people with information about their options. Online resources can also offer support and advice to people struggling with these issues.

5. Providing Information About How to Find Treatment

Many people struggling with mental health disorders don’t know how to find treatment. Information about how to find treatment can be helpful for people who are looking for help. Information about different treatment options can also be beneficial for people trying to decide what type of treatment they should receive.

An illustration of a psychedelic medicine fund.

Psychedelic medicines are making a comeback, and psychedelic investors are taking note. This blog post looked at the potential for early-stage psychedelic medicine investments to help save mental health. If you are interested in getting involved in the psychedelic medicine industry, contact us to learn more about our psychedelic companies funding.

Comments are closed.